Hyderabad-Based Natco Pharma Returns To Profit In Q4 As Business Grows In Us, Canada

In the March quarter, total revenue stood at Rs 898 crore, up 50.5 percent against Rs 596.8 crore in the year-ago period. Shares of Natco Pharma Ltd ended at Rs 635.10, up by Rs 5.75, or 0.91 percent on the BSE.

Related Keywords

Canada ,Brazil ,Jomy Jos Pullokaran ,Natco Pharma Ltd ,Natco Pharma Ltd On ,Natco Pharma Q4 Results ,Atco Pharma Ebitda Q4 ,Atco Pharma Q4 Net Profit ,Atco Pharma Q4 Revenue ,Atco Pharma Bse Share Price , ,